Filing Details
- Accession Number:
- 0001638599-20-000118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-03 17:13:52
- Reporting Period:
- 2019-09-30
- Accepted Time:
- 2020-02-03 17:13:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682639 | Eyenovia Inc. | EYEN | Pharmaceutical Preparations (2834) | 471178401 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744774 | M Michael Rowe | C/O Eyenovia, Inc. 295 Madison Avenue, Suite 2400 New York NY 10017 | Vice President, Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 | Acquisiton | 2019-09-30 | 100 | $3.84 | 1,400 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $6.30 | 2028-07-02 | 60,000 | 60,000 | Direct | |
Common Stock | Stock Option (right to buy) | $6.20 | 2028-07-24 | 19,874 | 19,874 | Direct | |
Common Stock | Stock Option (right to buy) | $3.11 | 2029-08-16 | 42,722 | 42,722 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2028-07-02 | 60,000 | 60,000 | Direct |
2028-07-24 | 19,874 | 19,874 | Direct |
2029-08-16 | 42,722 | 42,722 | Direct |
Footnotes
- The option became exercisable as to 1,666 shares on August 2, 2018 and becomes exercisable in equal 1,666 share amounts on each of the 35 one-month anniversaries thereafter.
- One-third of the option became exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
- One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.